Michael John Bickerdike

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Michael John Bickerdike is active.

Explore More

Publication

Featured researches published by Michael John Bickerdike.

Archive | 1999

Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists

David Reginald Adams; Jonathan Mark Bentley; Jonathan Richard Anthony Roffey; Richard John Hamlyn; Suneel Gaur; Matthew Duncton; James Edward Paul Davidson; Michael John Bickerdike; Ian A. Cliffe; Howard Langham Mansell

European Journal of Pharmacology | 1994

The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze

Michael John Bickerdike; Charles A. Marsden; Colin T. Dourish; Allan Fletcher

Bioorganic & Medicinal Chemistry Letters | 2004

Indoline derivatives as 5-HT2C receptor agonists

Jonathan Mark Bentley; David R. Adams; David Bebbington; Karen Benwell; Michael John Bickerdike; J. E. P. Davidson; Claire Elizabeth Dawson; Colin T. Dourish; M. A. J. Duncton; Suneel Gaur; Ashley Roger George; Paul R. Giles; R. J. Hamlyn; Guy A. Kennett; Antony R. Knight; Craig S. Malcolm; Howard Langham Mansell; Anil Misra; N. J. T. Monck; Robert Mark Pratt; Kathleen Quirk; Jonathan Richard Anthon Roffey; Steven P. Vickers; Ian A. Cliffe

Bioorganic & Medicinal Chemistry Letters | 2005

Identification of 4-methyl-1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles as 5-HT2C receptor agonists.

Stephan Röver; David R. Adams; Agnès Bénardeau; Jonathan Mark Bentley; Michael John Bickerdike; Anne Bourson; Ian A. Cliffe; P. Coassolo; J.E.P. Davidson; C.T. Dourish; Paul Hebeisen; Guy A. Kennett; Antony R. Knight; Craig S. Malcolm; Patrizio Mattei; Anil Misra; Jacques Mizrahi; M. Muller; Richard Hugh Philip Porter; Hans Richter; Sven Taylor; Steven P. Vickers

Neuropharmacology | 1995

Attenuation of CCK-induced aversion in rats on the elevated x-maze by the selective 5-HT1A receptor antagonists (+) WAY100135 and WAY100635.

Michael John Bickerdike; A. Fletcher; Charles A. Marsden

Bioorganic & Medicinal Chemistry Letters | 2006

Pyrrolo(iso)quinoline derivatives as 5-HT2C receptor agonists

David R. Adams; Jonathan Mark Bentley; Karen Benwell; Michael John Bickerdike; Corinna Dagmar Bodkin; Ian A. Cliffe; Colin T. Dourish; Ashley Roger George; Guy A. Kennett; Antony R. Knight; Craig S. Malcolm; Howard Langham Mansell; Anil Misra; Kathleen Quirk; Jonathan Richard Anthony Roffey; Steven P. Vickers

Archive | 2004

The use of azetidinecarboxamide derivatives in therapy

James Edward Paul Davidson; David Reginald Adams; Michael John Bickerdike; Allan Fletcher

Archive | 1977

Novel indole derivatives

Jonathan Mark Bentley; Michael John Bickerdike; Paul Hebeisen; Guy A. Kennett; Sean Lightowler; Patrizio Mattei; Jacques Mizrahi; Timothy James Morley; Jean-Marc Plancher; Hans Richter; Stephan Roever; Sven Taylor; Steven P. Vickers

Archive | 2006